Indaptus Therapeutics Competitors and Similar CompaniesClear all

Indaptus Therapeutics's competitors and similar companies include Seagen and Opsy.

	Indaptus Therapeutics Indaptus Therapeutics. is a biopharmaceutical company that specializes in cancer and other infectious disease treatment solutions.	Seagen Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer.	Opsy Opsy Holding (formerly WntResearch) is a biotech company that develops therapies for preventing cancer spread.
Founding Date	Founding Date 2021	Founding Date 1998	Founding Date 2007
Type	Type Public	Type Subsidiary	Type Public
Tags	Tags Healthcare oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare oncology pharma therapy
Locations	Locations HQ	Locations Bothell, US HQ Mississauga, CA Hørsholm, DK Rueil Malmaison, FR München, DE Milano, IT Schiphol, NL see more	Locations Gothenburg, SE HQ Lund, SE
Employees	Employees N/A	Employees 3,25622% increase	Employees 2
Valuation ($)	Valuation ($) 12.6 m	Valuation ($) N/A	Valuation ($) 721.5 k
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $2b (FY, 2022)	Revenue (est.) kr6.7m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods $410.1m (FY, 2022)	Cost of goods kr1.3m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit $1.6b (FY, 2022)	Gross profit kr5.4m (FY, 2025)
Net income	Net income N/A	Net income ($610.3m) (FY, 2022)	Net income (kr17.2m) (FY, 2025)

For sources of this data, please see the company profile

Bothell, US

Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer.

Gothenburg, SE

Employees

Opsy Holding (formerly WntResearch) is a biotech company that develops therapies for preventing cancer spread.

Financial